SCHIERMEIER ANDREW 4
4 · Intellia Therapeutics, Inc. · Filed Aug 2, 2019
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy
Transactions
- Award
Stock Option (Right to Buy)
2019-08-01+55,000→ 55,000 totalExercise: $18.09Exp: 2029-07-31→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]This option was granted on August 1, 2019 with respect to 55,000 shares of Common Stock, with 25% vesting on August 1, 2020 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.